Saad, E., An, J., Mehrabad, E. M., Labaki, C., Saliby, R. M., Semaan, K., Eid, M., Machaalani, M., Chehade, R. E. H., Steiner, C., Nawfal, R., Yekedüz, E., Shah, P. K., Asnani, A., Sun, M., Allen, E. M. V., Choi, J. K., Park, S. R., Gusev, A., Choueiri, T. K. (2025). Association of
            <i>IL7</i>
            germline variants with immune-related adverse events (irAEs) in cancer patients (pts) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.12129